SCHEMBL29892249

SCHEMBL29892249

c1ccc(-c2ccc(-c3ccc(Nc4ccc(-c5ccccc5)c(-c5ccccc5)c4)cc3)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
MAPT P10636 4/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
AR P10275 1/20 0.48
HSD17B10 Q99714 3/20 0.48
L3MBTL1 Q9Y468 3/20 0.48
TSHR P16473 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
ALOX12 P18054 2/20 0.48
ALOX15 P16050 1/20 0.48
PTGS1 P23219 1/20 0.48
SLC6A2 P23975 1/20 0.48
MAPK1 P28482 1/20 0.48
PTGS2 P35354 1/20 0.48
HTR2B P41595 1/20 0.48
APP P05067 1/20 0.47
CYP3A4 P08684 3/20 0.45
HPGD P15428 2/20 0.45
MAPK10 P53779 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29576303 1.00 ALDH1A1 (0.48) ALDH1A1MAPTMEN1KMT2AAR
SCHEMBL20582564 1.00 ALDH1A1 (0.48) ALDH1A1MAPTMEN1KMT2AAR
SCHEMBL19579533 1.00 ALDH1A1 (0.48) ALDH1A1MAPTMEN1KMT2AAR
SCHEMBL31245650 1.00 ALDH1A1 (0.48) ALDH1A1MAPTMEN1KMT2AAR
SCHEMBL31707426 1.00 ALDH1A1 (0.48) ALDH1A1MAPTMEN1KMT2AAR
SCHEMBL29825493 1.00 ALDH1A1 (0.48) ALDH1A1MAPTMEN1KMT2AAR
SCHEMBL19511796 1.00 ALDH1A1 (0.48) ALDH1A1MAPTMEN1KMT2AAR
SCHEMBL23765055 0.98 ALDH1A1 (0.52) ALDH1A1MAPTMEN1KMT2AAR
SCHEMBL20531464 0.98 ALDH1A1 (0.52) ALDH1A1MAPTMEN1KMT2AAR
SCHEMBL29406240 0.96 ALDH1A1 (0.54) ALDH1A1MAPTMEN1KMT2AAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4692058-A1 ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE Hodogaya Chemical Co., Ltd. (JP) 2026-02-11 EP disclosed
WO-2024204268-A1 ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE 保土谷化学工業株式会社 2024-10-03 WO disclosed
US-20240251665-A1 TRANSVERSE CURRENT SUPPRESSING MATERIAL, CARBAZOLE COMPOUND, HOLE-INJECTION LAYER AND ORGANIC ELECTROLUMINESCENT ELEMENT TOSOH CORPORATION (JP) 2024-07-25 US disclosed
WO-2022211123-A1 TRANSVERSE CURRENT SUPPRESSING MATERIAL, CARBAZOLE COMPOUND, HOLE INJECTION LAYER, AND ORGANIC ELECTROLUMINESCENT ELEMENT 東ソー株式会社 2022-10-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240251665-A1 TRANSVERSE CURRENT SUPPRESSING MATERIAL, CARBAZOLE COMPOUND, HOLE-INJECTION LAYER AND ORGANIC ELECTROLUMINESCENT ELEMENT AXIN2, FZD7, SLC39A3 ALDH1A1 3265/4885MAPT 3209/4885MEN1 1023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.